The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403 · cited 4×
“…Nature Publishing Group All rights reserved 0950-9232/05 $30.00 www.nature.com/onc cell motility through the deacetylation of a-tubulin, indicating that HDAC6 is related to cell migration rather than to transcriptional regulation (Hubbert et al., 2002; Haggarty et al., 2003; Palazzo et al., 2003).”
BackgroundInfluentialSelf-citationKawaguchi, Y., Kovacs, J. J., McLaurin, A., Vance, J. M., Ito, A., & Yao, T.-P. (2003) · Cell · doi:10.1016/s0092-8674(03)00939-5 · Cited by 1,524
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Self-citationEllis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770 · cited 5×
“Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer Shigehira Saji*,1, Masayo Kawakami1, Shin-ichi Hayashi2, Nobuyuki Yoshida3, Makiko Hirose1, Shin-ichiro Horiguchi4, Akihiro Itoh5, Nobuaki Funata4, Stuart L Schreiber6, Minoru Yoshida5 an…”
BackgroundMethodInfluentialSelf-citationBardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., & Senn, H.-J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3817 · Cited by 582
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Wade, P. A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.693 · Cited by 317
HDAC6 Expression Is Correlated with Better Survival in Breast Cancer
Zhang, Z., Yamashita, H., Toyama, T., Sugiura, H., Omoto, Y., Ando, Y., Mita, K., Hamaguchi, M., Hayashi, S.-I., & Iwase, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0455 · Cited by 293
Self-citationDevelopment of cDNA microarray for expression profiling of estrogen-responsive genes
Inoue, A., Yoshida, N., Omoto, Y., Oguchi, S., Yamori, T., Kiyama, R., & Hayashi, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290175 · Cited by 292
Self-citationTubulin acetylation and cell motility
Palazzo, A., Ackerman, B., & Gundersen, G. G. (2003) · Nature · doi:10.1038/421230a · Cited by 256
Malinda, K. M., Ponce, L., Kleinman, H. K., Shackelton, L. M., & Millis, A. J. T. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4511 · Cited by 254
Identification of a New Family of Higher Eukaryotic Histone Deacetylases
Verdel, A., & Khochbin, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2440 · Cited by 230
Expression, Function, and Clinical Implications of the Estrogen Receptor β in Human Lung Cancers
Omoto, Y., Kobayashi, Y., Nishida, K., Tsuchiya, E., Eguchi, H., Nakagawa, K., Ishikawa, Y., Yamori, T., Iwase, H., Fujii, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5158 · Cited by 197
Self-citationYoshida, N., Omoto, Y., Inoue, A., Eguchi, H., Kobayashi, Y., Kurosumi, M., Saji, S., Suemasu, K., Okazaki, T., Nakachi, K., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03239.x · Cited by 79
Self-citation
Cited by
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
HDAC family: What are the cancer relevant targets?
Witt, O., Deubzer, H. E., Milde, T., & Oehme, I. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.08.016 · Cited by 1,069
“showed a statistically significant difference in relapse-free survival and overall survival in favor of the HDAC6-positive group and HDAC6 expression was an independent prognostic indicator [76].”
BackgroundHistone deacetylases and cancer
Glozak, M. A., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210610 · Cited by 1,031
Histone deacetylases and cancer
Barneda-Zahonero, B., & Parra, M. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.003 · Cited by 446
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
Usman, S., Waseem, N. H., Nguyen, T. K. N., Mohsin, S., Jamal, A., Teh, M.-T., & Waseem, A. (2021) · Cancers · doi:10.3390/cancers13194985 · Cited by 430
Metadata
- Authors
- Saji, S., Kawakami, M., Hayashi, S.-I., Yoshida, N., Hirose, M., Horiguchi, S.-I., Itoh, A., Funata, N., Schreiber, S. L., Yoshida, M., & Toi, M.
- Venue
- Oncogene
- Published
- 2005-04-04
- Volume
- 24
- Issue
- 28
- Pages
- 4531-4539
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2046316599
- Cited by
- 258
- References
- 20
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.